Cargando…

Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial

INTRODUCTION: Clinicians routinely administer stress ulcer prophylaxis to mechanically ventilated patients in the intensive care unit (ICU), most commonly prescribing proton pump inhibitors (PPIs). However, the incidence of gastrointestinal (GI) bleeding from stress ulceration is low and recent obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhazzani, Waleed, Guyatt, Gordon, Marshall, John C., Hall, Richard, Muscedere, John, Lauzier, Francois, Thabane, Lehana, Alshahrani, Mohammed, English, Shane W., Arabi, Yaseen M., Deane, Adam M., Karachi, Tim, Rochwerg, Bram, Finfer, Simon, Daneman, Nick, Zytaruk, Nicole, Heel-Ansdell, Diane, Cook, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074211/
https://www.ncbi.nlm.nih.gov/pubmed/27920416
http://dx.doi.org/10.5144/0256-4947.2016.427
_version_ 1783344356903616512
author Alhazzani, Waleed
Guyatt, Gordon
Marshall, John C.
Hall, Richard
Muscedere, John
Lauzier, Francois
Thabane, Lehana
Alshahrani, Mohammed
English, Shane W.
Arabi, Yaseen M.
Deane, Adam M.
Karachi, Tim
Rochwerg, Bram
Finfer, Simon
Daneman, Nick
Zytaruk, Nicole
Heel-Ansdell, Diane
Cook, Deborah
author_facet Alhazzani, Waleed
Guyatt, Gordon
Marshall, John C.
Hall, Richard
Muscedere, John
Lauzier, Francois
Thabane, Lehana
Alshahrani, Mohammed
English, Shane W.
Arabi, Yaseen M.
Deane, Adam M.
Karachi, Tim
Rochwerg, Bram
Finfer, Simon
Daneman, Nick
Zytaruk, Nicole
Heel-Ansdell, Diane
Cook, Deborah
author_sort Alhazzani, Waleed
collection PubMed
description INTRODUCTION: Clinicians routinely administer stress ulcer prophylaxis to mechanically ventilated patients in the intensive care unit (ICU), most commonly prescribing proton pump inhibitors (PPIs). However, the incidence of gastrointestinal (GI) bleeding from stress ulceration is low and recent observational studies suggest these agents may increase infections. Therefore, a large randomized clinical trial (RCT) is needed to inform modern practice. The aim of this multicenter pilot trial is to determine the feasibility of performing a large RCT to investigate the efficacy and safety of withholding intravenous pantoprazole. METHODS AND ANALYSIS: We will include adult critically ill patients who have an anticipated duration of ventilation of ≥48 hours. We will exclude patients with acute or recent GI bleeding, pregnancy, dual antiplatelet therapy, poor prognosis or intent to withdraw life support, or previous enrolment in this or a confounding trial. Following informed consent, patients will be randomized to receive the intervention of placebo (0.9% NaCl) or intravenous pantoprazole 40 mg daily. Patients, families, clinicians, data collectors, adjudicators of outcome and statisticians will be blind to allocation. The three primary feasibility outcomes are the informed consent rate, recruitment rate, and protocol adherence. Clinical outcomes include clinically important upper GI bleeding, ventilator-associated pneumonia (VAP), Clostridium difficile infection, length of stay and mortality in ICU and hospital. ETHICS AND APPROVAL: This study has been approved by Health Canada, and research ethics board (REB) at each of the participating centers. TRIAL REGISTRATION NUMBER: This trial was registered on 31 October 2014. The trial registration number is NCT02290327. FUNDING: REVISE Pilot Trial is funded by Research Grant awarded by Physicians Services Incorporated, Dammam University Research Funds, Capital Health Authority Research Award Halifax, and Royal Adelaide Hospital Project Committee Grant.
format Online
Article
Text
id pubmed-6074211
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher King Faisal Specialist Hospital and Research Centre
record_format MEDLINE/PubMed
spelling pubmed-60742112018-09-21 Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial Alhazzani, Waleed Guyatt, Gordon Marshall, John C. Hall, Richard Muscedere, John Lauzier, Francois Thabane, Lehana Alshahrani, Mohammed English, Shane W. Arabi, Yaseen M. Deane, Adam M. Karachi, Tim Rochwerg, Bram Finfer, Simon Daneman, Nick Zytaruk, Nicole Heel-Ansdell, Diane Cook, Deborah Ann Saudi Med Clinical Trial Protocol INTRODUCTION: Clinicians routinely administer stress ulcer prophylaxis to mechanically ventilated patients in the intensive care unit (ICU), most commonly prescribing proton pump inhibitors (PPIs). However, the incidence of gastrointestinal (GI) bleeding from stress ulceration is low and recent observational studies suggest these agents may increase infections. Therefore, a large randomized clinical trial (RCT) is needed to inform modern practice. The aim of this multicenter pilot trial is to determine the feasibility of performing a large RCT to investigate the efficacy and safety of withholding intravenous pantoprazole. METHODS AND ANALYSIS: We will include adult critically ill patients who have an anticipated duration of ventilation of ≥48 hours. We will exclude patients with acute or recent GI bleeding, pregnancy, dual antiplatelet therapy, poor prognosis or intent to withdraw life support, or previous enrolment in this or a confounding trial. Following informed consent, patients will be randomized to receive the intervention of placebo (0.9% NaCl) or intravenous pantoprazole 40 mg daily. Patients, families, clinicians, data collectors, adjudicators of outcome and statisticians will be blind to allocation. The three primary feasibility outcomes are the informed consent rate, recruitment rate, and protocol adherence. Clinical outcomes include clinically important upper GI bleeding, ventilator-associated pneumonia (VAP), Clostridium difficile infection, length of stay and mortality in ICU and hospital. ETHICS AND APPROVAL: This study has been approved by Health Canada, and research ethics board (REB) at each of the participating centers. TRIAL REGISTRATION NUMBER: This trial was registered on 31 October 2014. The trial registration number is NCT02290327. FUNDING: REVISE Pilot Trial is funded by Research Grant awarded by Physicians Services Incorporated, Dammam University Research Funds, Capital Health Authority Research Award Halifax, and Royal Adelaide Hospital Project Committee Grant. King Faisal Specialist Hospital and Research Centre 2016 /pmc/articles/PMC6074211/ /pubmed/27920416 http://dx.doi.org/10.5144/0256-4947.2016.427 Text en Copyright © 2016, Annals of Saudi Medicine This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Clinical Trial Protocol
Alhazzani, Waleed
Guyatt, Gordon
Marshall, John C.
Hall, Richard
Muscedere, John
Lauzier, Francois
Thabane, Lehana
Alshahrani, Mohammed
English, Shane W.
Arabi, Yaseen M.
Deane, Adam M.
Karachi, Tim
Rochwerg, Bram
Finfer, Simon
Daneman, Nick
Zytaruk, Nicole
Heel-Ansdell, Diane
Cook, Deborah
Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial
title Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial
title_full Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial
title_fullStr Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial
title_full_unstemmed Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial
title_short Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial
title_sort re-evaluating the inhibition of stress erosions (revise): a protocol for pilot randomized controlled trial
topic Clinical Trial Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074211/
https://www.ncbi.nlm.nih.gov/pubmed/27920416
http://dx.doi.org/10.5144/0256-4947.2016.427
work_keys_str_mv AT alhazzaniwaleed reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT guyattgordon reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT marshalljohnc reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT hallrichard reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT muscederejohn reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT lauzierfrancois reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT thabanelehana reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT alshahranimohammed reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT englishshanew reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT arabiyaseenm reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT deaneadamm reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT karachitim reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT rochwergbram reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT finfersimon reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT danemannick reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT zytaruknicole reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT heelansdelldiane reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial
AT cookdeborah reevaluatingtheinhibitionofstresserosionsreviseaprotocolforpilotrandomizedcontrolledtrial